Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
Add more filters










Publication year range
1.
Eksp Klin Farmakol ; 61(2): 30-2, 1998.
Article in Russian | MEDLINE | ID: mdl-9621170

ABSTRACT

The effect of agents possessing antihypoxic and antioxidant activity, namely sodium oxybutyrate and emoxypin, on the functional state of the heart muscle was studied in experiments on dogs with epinephrine necroses of the myocardium. A marked cardioprotective effect was produced by sodium oxybutyrate infused intravenously (200 mg/kg) either 10 min or 2 hrs after myocardial damage had been modelled and by emoxypin (4 mg/kg; 0.4 mg/kg) infused intravenously 30 min after the damage.


Subject(s)
Antioxidants/therapeutic use , Cardiomyopathies/chemically induced , Cardiomyopathies/drug therapy , Cardiovascular Agents/therapeutic use , Picolines/therapeutic use , Sodium Oxybate/therapeutic use , Adrenergic Agonists , Animals , Cardiomyopathies/enzymology , Disease Models, Animal , Dogs , Dose-Response Relationship, Drug , Drug Evaluation, Preclinical , Epinephrine , Female , Male , Time Factors
2.
Eksp Klin Farmakol ; 61(1): 70-3, 1998.
Article in Russian | MEDLINE | ID: mdl-9575418

ABSTRACT

Catecholamine-induced myocardial necroses have their own peculiarities but the disorders in myocardial metabolism occurring in them do not differ in quality from those encountered in necroses caused by occlusion of the coronaries. Pharmacological regulation of the metabolism of a myocardium damaged by catecholamines may be accomplished by the same drugs which are used in necroses caused by coronary occlusion, but agents with antihypoxic and antioxidant activity are preferable.


Subject(s)
Cardiomyopathies/drug therapy , Cardiovascular Agents/therapeutic use , Catecholamines/toxicity , Heart/drug effects , Myocardium/metabolism , Myocardium/pathology , Animals , Cardiomyopathies/chemically induced , Cardiomyopathies/metabolism , Disease Models, Animal , Drug Evaluation, Preclinical , Necrosis
3.
Biull Eksp Biol Med ; 115(3): 271-2, 1993 Mar.
Article in Russian | MEDLINE | ID: mdl-8054619

ABSTRACT

The effects of dopamine (5 micrograms/kg.min) on the blood plasma glucose level and glycogen-phosphorylase activity in experimental coronary occlusion were studied. The absence of the raising of the plasma glucose level and glycogen-phosphorylase "a" and "b" activities has been observed in 25 min after the coronary occlusion. It is supposed that the functional improvement of the ischemized myocardium by dopamine (5 micrograms/kg.min) is the result of the stimulation of presynaptic D-2-dopaminergic and postsynaptic D-1-dopaminergic receptors in coronary arteries.


Subject(s)
Blood Glucose/metabolism , Coronary Disease/drug therapy , Dopamine/pharmacology , Phosphorylases/drug effects , Animals , Biomarkers/blood , Coronary Disease/blood , Coronary Disease/etiology , Dogs , Female , Male , Phosphorylases/blood
5.
Eksp Klin Farmakol ; 55(5): 33-6, 1992.
Article in Russian | MEDLINE | ID: mdl-1363945

ABSTRACT

The nonselective beta-blocker propranolol and the selective beta 1-adrenoblocker flusoxolol were tested for their effects on the activities of acid phosphatase, acid DNAase, cathepsin D, beta-glucosidase and beta-galactosidase in intact rat ventricular myocardial homogenates. The two drugs were found to have the most noticeable effect on the activity of three enzymes under study: acid phosphatase, beta-glucosidase and beta-galactosidase. They were able to stabilize lysosomal membranes during long-term homogenate preincubation at 37 degrees S. It is suggested that the mechanism of action of the drugs on intact rat ventricular myocardial lysosomes under the conditions of the study involves the binding of both propranolol and flusoxolol to beta-adrenoceptors on the lysosomes.


Subject(s)
Adrenergic beta-Antagonists/pharmacology , Heart/drug effects , Lysosomes/drug effects , Myocardium/enzymology , Propanolamines/pharmacology , Propranolol/pharmacology , Animals , Dose-Response Relationship, Drug , Enzyme Stability/drug effects , Heart Ventricles/drug effects , Heart Ventricles/enzymology , In Vitro Techniques , Lysosomes/enzymology , Male , Phenoxypropanolamines , Rats , Rats, Wistar , Temperature
6.
Biull Eksp Biol Med ; 112(11): 490-2, 1991 Nov.
Article in Russian | MEDLINE | ID: mdl-1667275

ABSTRACT

The influence of cardioselective beta-blockers, practolol and atenolol, on acid phosphatase, acid deoxyribonuclease, cathepsin D, beta-glucosidase and beta-galactosidase activities was studied in homogenates of intact rat ventricular myocardium. In the presence of drugs (1 x 10(-9)-1 x 10(-5) M) the activities of acid phosphatase, cathepsin D, beta-glucosidase and beta-galactosidase tended to diminish but the activity of acid deoxyribonuclease tended to increase. Some differences in the influence of drugs on the enzyme activities were removed by prolongation of preincubation of homogenates with drugs. It is supposed that the mechanism of influence of beta-blockers on lysosomes of the intact rat ventricular myocardium in conditions of this study includes the specific drug binding to beta-adrenergic receptors situated on lysosomes.


Subject(s)
Atenolol/pharmacology , Heart/drug effects , Lysosomes/drug effects , Myocardium/enzymology , Practolol/pharmacology , Animals , Dose-Response Relationship, Drug , Heart Ventricles/drug effects , Heart Ventricles/enzymology , In Vitro Techniques , Lysosomes/enzymology , Male , Rats , Rats, Inbred Strains , Receptors, Adrenergic, beta/drug effects , Receptors, Adrenergic, beta/metabolism , Time Factors
7.
Farmakol Toksikol ; 53(2): 75-80, 1990.
Article in Russian | MEDLINE | ID: mdl-2164489

ABSTRACT

Adrenergic drugs exert effects on the processes of potassium ions transmembrane distribution between the intra- and extracellular spaces. Drug-induced hypokalemia is the result of beta (predominantly beta-2) adrenergic stimulation. Arrhythmias in myocardial ischemia occur at the combination of hypercatecholaminemia and rapid transmembrane distribution of potassium ions between the intra- and extracellular spaces. The distribution results in the association of the increased local extracellular potassium concentration in the myocardium and rapidly developing hypokalemia.


Subject(s)
Coronary Disease/drug therapy , Extracellular Space/drug effects , Myocardial Infarction/drug therapy , Potassium/metabolism , Sympathomimetics/pharmacology , Animals , Arrhythmias, Cardiac/etiology , Arrhythmias, Cardiac/metabolism , Coronary Disease/complications , Coronary Disease/metabolism , Extracellular Space/metabolism , Humans , Myocardial Infarction/complications , Myocardial Infarction/metabolism , Receptors, Adrenergic, beta/drug effects , Receptors, Adrenergic, beta/metabolism , Sympathomimetics/therapeutic use
8.
Farmakol Toksikol ; 52(5): 19-23, 1989.
Article in Russian | MEDLINE | ID: mdl-2599071

ABSTRACT

In acute experiments on anesthetized dogs dopamine (10 micrograms/kg and 10 micrograms/kg/min) was shown to increase significantly the blood supply to ischemic regions and the minute heart volume at the background of insignificant systemic hypotension and tachycardia. When administered in a dose of 10 micrograms/kg/min dopamine increased the magnitude of the ratio of glycogen-phosphorylase b activity to total glycogen-phosphorylase activity in the blood plasma. Administration of 20 micrograms/kg of the drug did not produce a significant increase of the blood supply to ischemic regions and the minute heart volume in the presence of the tendency toward systemic hypotension and bradycardia.


Subject(s)
Coronary Disease/drug therapy , Dopamine/pharmacology , Hemodynamics/drug effects , Acute Disease , Animals , Collateral Circulation/drug effects , Collateral Circulation/physiology , Coronary Disease/enzymology , Coronary Disease/physiopathology , Dogs , Dopamine/therapeutic use , Dose-Response Relationship, Drug , Drug Evaluation, Preclinical , Female , Hemodynamics/physiology , Male , Time Factors
9.
Farmakol Toksikol ; 52(5): 28-31, 1989.
Article in Russian | MEDLINE | ID: mdl-2599073

ABSTRACT

The binding of 3H-dihydroalprenolol and 3H-quinuclidinyl benzylate to lysosomes of the rat ventricular myocardium vas studied. More than one type of specific binding sites of dihydroalprenolol and quinuclidinyl benzylate at the rat myocardium lysosomes were found. The association constants values differ from the known values of the association constants of the same ligands with plasmatic membranes of the mammalian myocardium.


Subject(s)
Alprenolol/analogs & derivatives , Dihydroalprenolol/pharmacokinetics , Lysosomes/enzymology , Myocardium/enzymology , Quinuclidines/pharmacokinetics , Quinuclidinyl Benzilate/pharmacokinetics , Animals , Heart Ventricles/enzymology , Ligands , Rats
10.
Farmakol Toksikol ; 51(2): 59-61, 1988.
Article in Russian | MEDLINE | ID: mdl-3378608

ABSTRACT

The effects of partusisten, novodrin and nonachlazine on the acid phosphatase and glycogenphosphorylase activities in the guinea pig ventricle myocardium were studied. The injection of partusisten (1 mg/kg) significantly increased the acid phosphatase activity and preserved the strong negative correlation between the free activity of acid phosphatase seen in control animals and the "free activity/total activity" ratio. Beta adrenergic agonists exerted different effects on the "glycogenphosphorylase B activity/glycogenphosphorylase A + B activity" ratio.


Subject(s)
Heart/drug effects , Intracellular Membranes/drug effects , Lysosomes/drug effects , Myocardium/enzymology , Phosphorylases/metabolism , Sympathomimetics/pharmacology , Acid Phosphatase/metabolism , Animals , Guinea Pigs , Heart Ventricles/drug effects , Heart Ventricles/enzymology , Intracellular Membranes/enzymology , Lysosomes/enzymology
12.
Farmakol Toksikol ; 49(4): 77-81, 1986.
Article in Russian | MEDLINE | ID: mdl-3758337

ABSTRACT

Experiments on the ischemic myocardial tissue of the rat in vitro showed that despite the fact that reserpine-induced depletion of the tissue catecholamine storage failed to affect the stability of lysosomal membranes, a combination of reserpine pretreatment of the animals with subsequent administration of nonachlazine at the low dose yielded stabilization of lysosomal membranes to a greater extent than administration of nonachlazine alone. The effects of nonachlazine (0.25 mg/kg) on the activity of creatine phosphokinase and total activity of acid phosphatase with and without reserpine pretreatment were similar.


Subject(s)
Acid Phosphatase/metabolism , Coronary Disease/drug therapy , Creatine Kinase/metabolism , Intracellular Membranes/drug effects , Lysosomes/drug effects , Myocardium/enzymology , Nonachlazine/therapeutic use , Phenothiazines/therapeutic use , Reserpine/therapeutic use , Animals , Coronary Disease/enzymology , Dose-Response Relationship, Drug , Drug Evaluation, Preclinical , Drug Therapy, Combination , In Vitro Techniques , Intracellular Membranes/enzymology , Lysosomes/enzymology , Male , Rats , Time Factors
13.
Farmakol Toksikol ; 48(3): 41-5, 1985.
Article in Russian | MEDLINE | ID: mdl-4029378

ABSTRACT

It has been shown in vitro that nonachlazine stabilizes rat myocardial lysosomal membranes and activates total acid phosphatase in homogenates of rat myocardium. Preliminary addition of nonachlazine to homogenates in two different final concentrations produces unequal changes in total and free activity of acid phosphatase and cathepsin D during 2.5-hour incubation of homogenates at 37 degrees C.


Subject(s)
Heart/drug effects , Intracellular Membranes/drug effects , Lysosomes/drug effects , Nonachlazine/pharmacology , Phenothiazines/pharmacology , Temperature , Acid Phosphatase/metabolism , Animals , Cathepsin D/metabolism , Dose-Response Relationship, Drug , In Vitro Techniques , Intracellular Membranes/enzymology , Lysosomes/enzymology , Male , Myocardium/enzymology , Myocardium/ultrastructure , Rats , Time Factors
16.
Vopr Med Khim ; 28(6): 56-9, 1982.
Article in Russian | MEDLINE | ID: mdl-7157722

ABSTRACT

Under conditions of acute ischemia spontaneous fibrillation which developed in heart ventricles as well as arrhythmias which were medicamentally provoked both were accompanied by a decrease in activity of glycogen phosphorylase a. At the same time, there was a distinct increase of non-phosphorylated isoenzyme ratio to the total phosphorylase activity of the tissue and the total glycogen pool was decreased. The decrease in activity of glycogen phosphorylase a, after pharmacological correction of metabolism of highly ischemized myocardium using obzidan and digoxin at therapeutic doses, occurred simultaneously with a decrease in the level of phosphorylase b activity in the tissue. A hypothesis, considering an increase in glycogenolysis as a trigger mechanism in development of ventricle fibrillation under conditions of acute coronary occlusion, is criticized.


Subject(s)
Coronary Disease/metabolism , Glycogen/metabolism , Glycolysis , Myocardium/metabolism , Ventricular Fibrillation/metabolism , Animals , Coronary Disease/complications , Digoxin/pharmacology , Dogs , Female , Male , Phosphorylases/metabolism , Propranolol/pharmacology , Ventricular Fibrillation/etiology
17.
Farmakol Toksikol ; 45(4): 41-6, 1982.
Article in Russian | MEDLINE | ID: mdl-7128783

ABSTRACT

It has been shown that a single intravenous injection of obsidan (0.1 mg/kg) to dogs during acute coronary occlusion results in a decrease in the activities of "a" phosphorylase, Mg-dependent ATPase, creatine phosphokinase, succinate dehydrogenase and cytochrome-c-oxidase, in a slight lowering of the ATP content accompanied by the increased content of AMP and unchanged concentration of creatine phosphate. Repeated injections of the drug in the same dose raise the activities of the enzymes up to the control level and produce activation of glycogenolysis and succinate dehydrogenase during the reparative period. The drug favours the preservation of "b" phosphorylase activity in the infarcted tissue and does not change the content of adenine nucleotides and creatine phosphate upon prolonged application.


Subject(s)
Coronary Disease/metabolism , Energy Metabolism/drug effects , Heart/drug effects , Myocardium/metabolism , Propranolol/therapeutic use , Animals , Coronary Disease/drug therapy , Dogs , Drug Evaluation, Preclinical , Female , Male , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...